LLY

Lilly(Eli) & Co

Feb 05 • 04:00PM ET

1,020.84

-86.28 -7.79 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 1:50 PMEli Lilly shares fall after discontinuing three clinical assets, including Prevail-acquired dementia gene therapy LY3884963 for lack of efficacy, and amid price-competition worries from Hims’ $49 compounded Wegovy; Cantor Fitzgerald raises its price target to $1,205 from $985 and reiterates Overweight, citing strong 2026 guidance and an upbeat incretin sales outlook.

Peers: NVO JNJ ABBV MRK AZN-D AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT IVW

Scroll to Statements

Index	S&P 500	P/E	44.47	EPS (ttm)	22.96	Insider Own	9.93%	Shs Outstand	945.38M	Perf Week	-0.32%
Market Cap	965.09B	Forward P/E	24.82	EPS next Y	41.13	Insider Trans	-3.93%	Shs Float	851.50M	Perf Month	-4.06%
Enterprise Value	997.74B	PEG	0.93	EPS next Q	7.20	Inst Own	73.33%	Short Float	0.90%	Perf Quarter	12.57%
Income	20.64B	P/S	14.81	EPS this Y	37.52%	Inst Trans	-1.17%	Short Ratio	2.21	Perf Half Y	36.77%
Sales	65.18B	P/B	40.58	EPS next Y	23.54%	ROA	19.33%	Short Interest	7.70M	Perf YTD	-5.01%
Book/sh	25.16	P/C	97.35	EPS next 5Y	26.79%	ROE	96.82%	52W High	1133.95 -9.97%	Perf Year	23.58%
Cash/sh	10.49	P/FCF	104.09	EPS past 3/5Y	49.25% 27.59%	ROIC	31.91%	52W Low	623.78 63.65%	Perf 3Y	196.63%
Dividend Est.	6.56 (0.64%)	EV/EBITDA	35.27	Sales past 3/5Y	31.69% 21.58%	Gross Margin	85.40%	Volatility	4.35% 3.44%	Perf 5Y	390.86%
Dividend TTM	6.00 (0.59%)	EV/Sales	15.31	EPS Y/Y TTM	120.94%	Oper. Margin	45.56%	ATR (14)	41.96	Perf 10Y	1229.05%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	1.24	Sales Y/Y TTM	44.70%	Profit Margin	31.66%	RSI (14)	45.87	Recom	1.62
Dividend Gr. 3/5Y	15.24% 15.18%	Current Ratio	1.55	EPS Q/Q	58.78%	SMA20	-3.17%	Beta	0.39	Target Price	1225.88
Payout	26.14%	Debt/Eq	1.79	Sales Q/Q	42.56%	SMA50	-3.21%	Rel Volume	2.21	Prev Close	1107.12
Employees	47000	LT Debt/Eq	1.72	Earnings	Feb 04 BMO	SMA200	18.93%	Avg Volume	3.49M	Price	1020.84
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.10% 7.51%	Trades		Volume	7,700,741	Change	-7.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025

Show Previous Ratings

Today 09:51AM	Hims Is Already Knocking Off Novo's Wegovy Pill - For Just $49 A Month (Investor's Business Daily) -7.79%
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
04:08PM	Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly (Reuters)
11:56AM	Hims & Hers Is Introducing a Cheaper Wegovy Copycat. Novo Nordisk Stock Falls. (Barrons.com)
01:49PM	Lilly stops development of three drugs, including gene therapy (Clinical Trials Arena)
01:44PM	Loading…
01:44PM	Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst (Benzinga)
01:15PM	Hims & Hers offers cheaper weight-loss pill in a shock to Novo (Reuters Videos)
11:56AM	Why Eli Lilly (LLY) Shares Are Getting Obliterated Today (StockStory)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
09:36AM	Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall (Investing.com)
09:34AM	The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles (MarketBeat)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:26AM	Eli Lilly and Company Q4 Earnings Call Highlights (MarketBeat)
02:28AM	Loading…
02:28AM	Eli Lilly (LLY) Skyrockets as Profits Soar 95% (Insider Monkey)
12:38AM	LLY Q4 Deep Dive: Obesity Medicines, Pipeline Progress, and Market Expansion Drive Outperformance (StockStory)
Feb-04-26 10:38PM	Why Eli Lilly Stock Soared Today (Motley Fool) +10.33%
06:44PM	Patient preference is leaning towards Eli Lilly's weight loss drugs, says Guggenheim's Fernandez (CNBC TV)
05:39PM	Dow Jones Futures: Google Lifts Ailing Techs Late On Strong Earnings, Huge AI Spending (Investor's Business Daily)
05:28PM	Stocks to Watch Wednesday Recap: AMD, Super Micro, Chipotle (The Wall Street Journal)
04:41PM	These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More (Barrons.com)
04:33PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
04:21PM	Eli Lilly Stock Soars While Novo Nordisk SinksWhy the Weight-Loss Leaders Are Headed in Opposite Directions (Investopedia)
04:09PM	Novo Continues Two-Day Plunge As CFO Acknowledges 'Extraordinary' Challenges In 2026 (Investor's Business Daily)
04:09PM	Eli Lilly Surges On 'Assertive' Guidance That Assuages Novo Nordisk-Tied Worries (Investor's Business Daily)
04:05PM	Eli Lilly and Co (LLY) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
04:00PM	Stock market today: S&P 500, Nasdaq fall for 2nd day as tech slides on AI worries with Google earnings ahead (Yahoo Finance)
03:48PM	Stock market today: S&P 500, Nasdaq sink as AI worries fuel return to tech sell-off ahead of Google earnings (Yahoo Finance)
02:55PM	Nasdaq sinks as AMD fuels further tech slide (Proactive)
02:39PM	Loading…
02:39PM	Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank (24/7 Wall St.)
02:11PM	Eli Lilly stock surges after company touts strong sales outlook as rival Novo Nordisk continues plunge (Yahoo Finance)
02:02PM	In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk (Benzinga)
01:43PM	Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar (CNBC TV)
01:38PM	Eli Lilly soars past expectations to hit 45% sales growth in 2025 (Pharmaceutical Technology)
01:20PM	Software Stocks Plummet, Bitcoin Erases Post-Trump Election Rally: What's Moving Markets Wednesday? (Benzinga)
12:32PM	These Stocks Are Todays Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More (Barrons.com)
12:29PM	Eli Lilly Q4 2025 Earnings Call Transcript (Benzinga)
12:26PM	Eli Lilly (LLY) Stock Trades Up, Here Is Why (StockStory)
12:20PM	Novo Nordisk Stock Extends Losses as Ozempic Maker Sees Sales Falling in 2026 (Barrons.com)
12:10PM	Eli Lilly Guides Up to 27% Sales Growth as Obesity Demand Surges (GuruFocus.com)
11:40AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
11:35AM	Eli Lilly (LLY) Q4 2025 Earnings Call Transcript (Motley Fool)
11:30AM	Here's What Key Metrics Tell Us About Lilly (LLY) Q4 Earnings (Zacks)
11:21AM	Eli Lilly Again Tops $1 Trillion Market Cap. Earnings Show the Stock Can Still Surprise. (Barrons.com)
11:07AM	Stock market today: Dow jumps, S&P 500, Nasdaq fall with AI worries in focus ahead of Google earnings (Yahoo Finance)
11:06AM	Eli Lilly, Novo Nordisk, AbbVie: Pharma earnings roundup (Yahoo Finance Video)
10:52AM	Eli Lilly Stock Eyes Best Day Since October After Quarterly Beat (Schaeffer's Research)
10:49AM	ADP Payrolls Come in Way Below Expectations (Zacks)
10:22AM	Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance (Zacks)
10:19AM	AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus (Zacks)
10:19AM	ADP Jobs Lower, Q4 Earnings Reports Up (Zacks)
10:16AM	Stock Market Today: Dow Rises But Nasdaq Lags On Surprise Jobs Data; Eli Lilly Soars (Live Coverage) (Investor's Business Daily)
09:38AM	Eli Lilly vs. Novo Nordisk: Fortunes Diverge for the Weight-Loss Drug Titans (The Wall Street Journal)
09:37AM	Company News for Feb 4, 2026 (Zacks)
09:32AM	Eli Lilly Stock Jumps on Strong Weight-Loss Drug Outlook (GuruFocus.com)
09:30AM	Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook (Zacks)
09:28AM	Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US (Bloomberg)
09:27AM	Eli Lilly, Uber, Chipotle: Earnings Roundup (Yahoo Finance Video)
09:16AM	NVO Q4 Earnings & Sales Beat Estimates, Stock Down on Poor 2026 View (Zacks)
09:01AM	The weight loss drug giants are going in opposite directions (Quartz)
08:48AM	Novo Nordisk A/S Q4 Earnings Call Highlights (MarketBeat)
08:47AM	Eli Lilly leaves Novo Nordisk in the dust in weight loss drug race (Quartz)
08:39AM	Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs (Benzinga)
08:36AM	Eli Lilly Earnings Show the Stock Can Still Surprise (Barrons.com)
08:24AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:18AM	AbbVie Earnings Beat Wall Street Expectations. The Stock Is Falling Anyway. (Barrons.com)
08:15AM	Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales Double (Investor's Business Daily)
07:55AM	Eli Lilly (LLY) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:54AM	Novo Nordisk Warns Sales Could Fall Up to 13%, Shares Drop 20% (GuruFocus.com)
07:30AM	Earnings live: Supermicro, Eli Lilly stocks pop on upbeat forecasts, AMD and Uber slide (Yahoo Finance)
07:22AM	Eli Lilly Profit Rises as Weight-Loss Drug Demand Surges (The Wall Street Journal)
07:21AM	Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies (MarketWatch)
06:56AM	Eli Lilly Stock Jumps on Strong Earnings. Weight-Loss Drugs Have Something to Do With It. (Barrons.com)
06:54AM	Eli Lilly sees 2026 profit above estimates as demand for weightloss drugs soars (Reuters)
06:51AM	Lilly: Q4 Earnings Snapshot (Associated Press Finance)
06:51AM	Eli Lilly (NYSE:LLY) Reports Strong Q4 CY2025, Stock Soars (StockStory)
06:45AM	Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance (PR Newswire)
06:35AM	Does Stanley Druckenmiller Know Something Wall Street Doesn't? He Dumped All of His Shares in a Company Dominating a Market That May Soon Be Worth $100 Billion and Opened Positions in 3 AI Giants. (Motley Fool)
05:24AM	Uber and Alphabet headline earnings slate (MarketWatch)
05:23AM	Stock Market Today: Dow Futures Gain, Nasdaq Drops As Trump Signs Bill To End Partial Shutdown-AMD, Super Micro Computer, Eli Lilly In Focus (Benzinga)
04:36AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
04:24AM	Stock Market Today: Dow, S&P 500 and Nasdaq consolidate after software rout; AMD results weigh; Alphabet earnings on tap; gold recovers $5,000 level. (MarketWatch)
12:01AM	Treatment Advances Position Lilly as Weight-Loss Heavyweight (The Daily Upside)
Feb-03-26 10:19PM	Hair Loss Biopharma Firm Veradermics Raises $256 Million in IPO (Bloomberg)
07:58PM	Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics (Motley Fool)
07:09PM	Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook (Motley Fool)
07:00PM	Alphabet earnings, Eli Lilly Q4 results, ADP data: What to Watch (Yahoo Finance Video)
06:45PM	Stock market today: S&P 500, Nasdaq futures fall after AI-fueled sell-off, with Google earnings on deck (Yahoo Finance)
05:17PM	As Novo Nordisk Stock Breaks Below Key Support Levels, Should You Buy the Dip? (Barchart)
02:48PM	Obesity Drug Bets Get a Reality Checkbut Investors Shouldnt Panic (The Wall Street Journal)
01:43PM	Novo Nordisk's stock tumbles as drugmaker lays out case for declining sales in 2026 (MarketWatch)
01:31PM	Novo Crashes After Projecting 2026 Decline; Surprising With Day-Early Report (Investor's Business Daily)
12:49PM	Novo Nordisk shares plunge amid lower 2026 sales outlook (Investing.com)
12:27PM	Eli Lilly Stock Falls Ahead of Earnings -- Phase 3 Trials Could Fuel Next Wave of Growth (GuruFocus.com)
12:05PM	Pfizer Dives; Why Lilly's Zepbound Still Looks Like The Weight-Loss Heavyweight (Investor's Business Daily)
12:02PM	Novo Warns Sales to Tumble on Tougher Competition in US (Bloomberg)
11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
10:32AM	Pfizer Stock Drops on Obesity-Drug Study Data (The Wall Street Journal)
10:04AM	Walmart Hits $1 Trillion Valuation (The Wall Street Journal)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience